Patients with coeliac disease demonstrate concurrent autoimmune diseases more frequently (∼5%) than healthy individuals, and patients with autoimmune diseases often have coeliac disease, particularly those with diabetes or thyroid disease
Screening for coeliac disease in patients with autoimmune disease should be done regularly by evaluating serum antibodies (serological testing), although negative serology results do not entirely exclude coeliac disease
HLA typing offers a good negative predictive value, but only a modest positive predictive value
Gastroduodenoscopy whilst on gluten-containing diet is required for final diagnosis in adults, whereas HLA typing is part of the recent diagnostic work-up in children (many can be diagnosed without endoscopy)
Extensive genetic overlap exists between coeliac disease and other autoimmune diseases and current genetic risk profiling does not enable a precise prediction of disease development
Coeliac disease is a treatable, gluten-induced disease that often occurs concurrently with other autoimmune diseases. In genetic studies since 2007, a partial genetic overlap between these diseases has been revealed and further insights into the pathophysiology of coeliac disease and autoimmunity have been gained. However, genetic screening is not sensitive and specific enough to accurately predict disease development. The current method to diagnose individuals with coeliac disease is serological testing for the presence of autoantibodies whilst the patient is on a regular, gluten-containing diet, followed by gastroduodenoscopy with duodenal biopsy. Serological test results can also predict the probability of coeliac disease development, even if asymptomatic. In patients with autoimmune diseases known to occur alongside coeliac disease (particularly type 1 diabetes mellitus or thyroid disorders), disease screening—and subsequent treatment if coeliac disease is detected—could have beneficial effects on progression or potential complications of both diseases, owing to the effectiveness of gluten-free dietary interventions in coeliac disease. However, whether diagnosis of coeliac disease and subsequent dietary treatment can prevent autoimmune diseases is debated. In this Review, the genetic and immunological features of coeliac disease, overlap with other autoimmune diseases and implications for current screening strategies will be discussed.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Single cell transcriptomic analysis of the immune cell compartment in the human small intestine and in Celiac disease
Nature Communications Open Access 22 August 2022
Exploring celiac disease candidate pathways by global gene expression profiling and gene network cluster analysis
Scientific Reports Open Access 01 October 2020
BMC Medicine Open Access 23 July 2019
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
Prices may be subject to local taxes which are calculated during checkout
Abadie, V., Sollid, L. M., Barreiro, L. B. & Jabri, B. Integration of genetic and immunological insights into a model of celiac disease pathogenesis. Annu. Rev. Immunol. 29, 493–525 (2011).
Ludvigsson, J. F. et al. The Oslo definitions for coeliac disease and related terms. Gut 62, 43–52 (2013).
Ludvigsson, J. F. et al. Diagnosis and management of adult coeliac disease: guidelines from the British Society of Gastroenterology. Gut 63, 1210–1228 (2014).
Rampertab, S. D., Pooran, N., Brar, P., Singh, P. & Green, P. H. Trends in the presentation of celiac disease. Am. J. Med. 119, 355 e9–e14 (2006).
Sollid, L. M. & Jabri, B. Triggers and drivers of autoimmunity: lessons from coeliac disease. Nat. Rev. Immunol. 13, 294–302 (2013).
Sollid, L. M. et al. Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer. J. Exp. Med. 169, 345–350 (1989).
Anderson, R. P. et al. A novel serogenetic approach determines the community prevalence of celiac disease and informs improved diagnostic pathways. BMC Med. 11, 188 (2013).
Johnson, T. C. et al. Relationship of HLA-DQ8 and severity of celiac disease: comparison of New York and Parisian cohorts. Clin. Gastroenterol. Hepatol. 2, 888–894 (2004).
Agardh, D. et al. Clinical features of celiac disease: a prospective birth cohort. Pediatrics 135, 627–634 (2015).
Thomas, H. J. et al. Contribution of histological, serological, and genetic factors to the clinical heterogeneity of adult-onset coeliac disease. Scand. J. Gastroenterol. 44, 1076–1083 (2009).
de Haas, E. C., Kumar, V. & Wijmenga, C. in Celiac Disease (Clinical Gastroenterology) (eds Rampertab, S. D. & Mullin, G. E.) 53–66 (Springer Science+Business Media, 2014).
Parkes, M., Cortes, A., van Heel, D. A. & Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013).
Fasano, A. et al. Prevalence of celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study. Arch. Intern. Med. 163, 286–292 (2003).
Ludvigsson, J. F. et al. Screening for celiac disease in the general population and in high-risk groups. United European Gastroenterol. J. 3, 106–120 (2015).
Abdul Sultan, A. et al. Causes of death in people with coeliac disease in England compared with the general population: a competing risk analysis. Gut 64, 1220–1226 (2015).
Junker, Y. et al. Wheat amylase trypsin inhibitors drive intestinal inflammation via activation of Toll-like receptor 4. J. Exp. Med. 209, 2395–2408 (2012).
Lammers, K. M. et al. Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3. Gastroenterology 135, 194–204 (2008).
Palova-Jelinkova, L. et al. Pepsin digest of wheat gliadin fraction increases production of IL-1β via TLR4/MyD88/TRIF/MAPK/NF-kappaB signaling pathway and an NLRP3 inflammasome activation. PLoS ONE 8, e62426 (2013).
Barone, M. V., Troncone, R. & Auricchio, S. Gliadin peptides as triggers of the proliferative and stress/innate immune response of the celiac small intestinal mucosa. Int. J. Mol. Sci. 15, 20518–20537 (2014).
Sollid, L. M., Qiao, S. W., Anderson, R. P., Gianfrani, C. & Koning, F. Nomenclature and listing of celiac disease relevant gluten T-cell epitopes restricted by HLA-DQ molecules. Immunogenetics 64, 455–460 (2012).
Antvorskov, J. C., Josefsen, K., Engkilde, K., Funda, D. P. & Buschard, K. Dietary gluten and the development of type 1 diabetes. Diabetologia 57, 1770–1780 (2014).
Maurano, F. et al. Small intestinal enteropathy in non-obese diabetic mice fed a diet containing wheat. Diabetologia 48, 931–937 (2005).
Sblattero, D. et al. Characterization of the anti-tissue transglutaminase antibody response in nonobese diabetic mice. J. Immunol. 174, 5830–5836 (2005).
Marietta, E. V. et al. Low incidence of spontaneous type 1 diabetes in non-obese diabetic mice raised on gluten-free diets is associated with changes in the intestinal microbiome. PLoS ONE 8, e78687 (2013).
Ejsing-Duun, M., Josephsen, J., Aasted, B., Buschard, K. & Hansen, A. K. Dietary gluten reduces the number of intestinal regulatory T cells in mice. Scand. J. Immunol. 67, 553–559 (2008).
Larsen, J. et al. Dietary gluten increases natural killer cell cytotoxicity and cytokine secretion. Eur. J. Immunol. 44, 3056–3067 (2014).
Adlercreutz, E. H. et al. A gluten-free diet lowers NKG2D and ligand expression in BALB/c and non-obese diabetic (NOD) mice. Clin. Exp. Immunol. 177, 391–403 (2014).
Schuppan, D., Pickert, G., Ashfaq-Khan, M. & Zevallos, V. Non-celiac wheat sensitivity: Differential diagnosis, triggers and implications. Best Pract. Res. Clin. Gastroenterol. 29, 469–476 (2015).
Dieterich, W. et al. Identification of tissue transglutaminase as the autoantigen of celiac disease. Nat. Med. 3, 797–801 (1997).
Sardy, M., Karpati, S., Merkl, B., Paulsson, M. & Smyth, N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J. Exp. Med. 195, 747–757 (2002).
Hadjivassiliou, M. et al. Transglutaminase 6 antibodies in the diagnosis of gluten ataxia. Neurology 80, 1740–1745 (2013).
Sollid, L. M., Molberg, O., McAdam, S. & Lundin, K. E. Autoantibodies in coeliac disease: tissue transglutaminase—guilt by association? Gut 41, 851–852 (1997).
Sulkanen, S. et al. Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac disease. Gastroenterology 115, 1322–1328 (1998).
Sjober, K. et al. Factor XIII and tissue transglutaminase antibodies in coeliac and inflammatory bowel disease. Autoimmunity 35, 357–364 (2002).
Alaedini, A. & Green, P. H. Autoantibodies in celiac disease. Autoimmunity 41, 19–26 (2008).
Stordal, K., Bakken, I. J., Suren, P. & Stene, L. C. Epidemiology of coeliac disease and comorbidity in Norwegian children. J. Pediatr. Gastroenterol. Nutr. 57, 467–471 (2013).
Emilsson, L., Wijmenga, C., Murray, J. A. & Ludvigsson, J. F. Autoimmune disease in first-degree relatives and spouses of individuals with celiac disease. Clin. Gastroenterol. Hepatol 13, 1271–1277 (2015).
Elfstrom, P., Sundstrom, J. & Ludvigsson, J. F. Systematic review with meta-analysis: associations between coeliac disease and type 1 diabetes. Aliment Pharmacol. Ther. 40, 1123–1132 (2014).
Ludvigsson, J. F., Ludvigsson, J., Ekbom, A. & Montgomery, S. M. Celiac disease and risk of subsequent type 1 diabetes: a general population cohort study of children and adolescents. Diabetes Care 29, 2483–2488 (2006).
Kahaly, G. J. & Schuppan, D. Celiac disease and endocrine autoimmunity. Dig. Dis. 33, 155–161 (2015).
Borchers, A. T., Uibo, R. & Gershwin, M. E. The geoepidemiology of type 1 diabetes. Autoimmun. Rev. 9, A355–A365 (2010).
Bjornstad, P., Snell-Bergeon, J. K., Nadeau, K. J. & Maahs, D. M. Insulin sensitivity and complications in type 1 diabetes: new insights. World J. Diabetes 6, 8–16 (2015).
Collin, P., Kaukinen, K., Valimaki, M. & Salmi, J. Endocrinological disorders and celiac disease. Endocr. Rev. 23, 464–483 (2002).
Elfstrom, P., Montgomery, S. M., Kampe, O., Ekbom, A. & Ludvigsson, J. F. Risk of thyroid disease in individuals with celiac disease. J. Clin. Endocrinol. Metab. 93, 3915–3921 (2008).
Ponto, K. A. et al. Thyroid-associated orbitopathy is linked to gastrointestinal autoimmunity. Clin. Exp. Immunol. 178, 57–64 (2014).
Iltanen, S. et al. Celiac disease and markers of celiac disease latency in patients with primary Sjogren's syndrome. Am. J. Gastroenterol. 94, 1042–1046 (1999).
Collin, P. & Reunala, T. Recognition and management of the cutaneous manifestations of celiac disease: a guide for dermatologists. Am. J. Clin. Dermatol. 4, 13–20 (2003).
Caproni, M., Antiga, E., Melani, L., Fabbri, P. & Italian Group for Cutaneous, I. Guidelines for the diagnosis and treatment of dermatitis herpetiformis. J. Eur. Acad. Dermatol. Venereol. 23, 633–638 (2009).
West, J., Fleming, K. M., Tata, L. J., Card, T. R. & Crooks, C. J. Incidence and prevalence of celiac disease and dermatitis herpetiformis in the UK over two decades: population-based study. Am. J. Gastroenterol. 109, 757–768 (2014).
Salmi, T. T., Hervonen, K., Kautiainen, H., Collin, P. & Reunala, T. Prevalence and incidence of dermatitis herpetiformis: a 40-year prospective study from Finland. Br. J. Dermatol. 165, 354–359 (2011).
Rubio-Tapia, A. & Murray, J. A. The liver in celiac disease. Hepatology 46, 1650–1658 (2007).
Caprai, S. et al. Autoimmune liver disease associated with celiac disease in childhood: a multicenter study. Clin. Gastroenterol. Hepatol. 6, 803–806 (2008).
Naess, S. et al. Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population. PLoS ONE 9, e114486 (2014).
Fosby, B. et al. Liver transplantation in the Nordic countries—An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982–2013. Scand. J. Gastroenterol. 50, 797–808 (2015).
Hadjivassiliou, M. et al. Neuropathy associated with gluten sensitivity. J. Neurol. Neurosurg. Psychiatry 77, 1262–1266 (2006).
Ong, M. S., Kohane, I. S., Cai, T., Gorman, M. P. & Mandl, K. D. Population-level evidence for an autoimmune etiology of epilepsy. JAMA Neurol. 71, 569–574 (2014).
Hadjivassiliou, M., Sanders, D. S., Woodroofe, N., Williamson, C. & Grunewald, R. A. Gluten ataxia. Cerebellum 7, 494–498 (2008).
Ludvigsson, J. F., Osby, U., Ekbom, A. & Montgomery, S. M. Coeliac disease and risk of schizophrenia and other psychosis: a general population cohort study. Scand. J. Gastroenterol. 42, 179–185 (2007).
van Heel, D. A. et al. A genome-wide association study for celiac disease identifies risk variants in the region harboring IL2 and IL21. Nat. Genet. 39, 827–829 (2007).
Dubois, P. C. et al. Multiple common variants for celiac disease influencing immune gene expression. Nat. Genet. 42, 295–302 (2010).
Monsuur, A. J. et al. Effective detection of human leukocyte antigen risk alleles in celiac disease using tag single nucleotide polymorphisms. PLoS ONE 3, e2270 (2008).
Gutierrez-Achury, J. et al. Fine mapping in the MHC region accounts for 18% additional genetic risk for celiac disease. Nat. Genet. 46, 577–578 (2015).
Kumar, V., Wijmenga, C. & Xavier, R. J. Genetics of immune-mediated disorders: from genome-wide association to molecular mechanism. Curr. Opin. Immunol. 31, 51–57 (2014).
Kumar, V., Wijmenga, C. & Withoff, S. From genome-wide association studies to disease mechanisms: celiac disease as a model for autoimmune diseases. Semin. Immunopathol. 34, 567–580 (2012).
Wijmenga, C. & Gutierrez-Achury, J. Celiac disease genetics: past, present and future challenges. J. Pediatr. Gastroenterol. Nutr. 59 (Suppl. 1), S4–S7 (2014).
Ricano-Ponce, I. & Wijmenga, C. Mapping of immune-mediated disease genes. Annu. Rev. Genomics Hum. Genet. 14, 325–353 (2013).
Nikula, T. et al. A human ImmunoChip cDNA microarray provides a comprehensive tool to study immune responses. J. Immunol. Methods 303, 122–134 (2005).
Cotsapas, C. et al. Pervasive sharing of genetic effects in autoimmune disease. PLoS Genet. 7, e1002254 (2011).
Zhernakova, A., Withoff, S. & Wijmenga, C. Clinical implications of shared genetics and pathogenesis in autoimmune diseases. Nat. Rev. Endocrinol. 9, 646–659 (2013).
Plenge, R. M., Scolnick, E. M. & Altshuler, D. Validating therapeutic targets through human genetics. Nat. Rev. Drug Discov. 12, 581–594 (2013).
Baurecht, H. et al. Genome-wide comparative Analysis of atopic dermatitis and psoriasis gives insight into opposing genetic mechanisms. Am. J. Hum. Genet. 96, 104–120 (2015).
Eaton, W. W., Rose, N. R., Kalaydjian, A., Pedersen, M. G. & Mortensen, P. B. Epidemiology of autoimmune diseases in Denmark. J. Autoimmun. 29, 1–9 (2007).
Patsopoulos, N. A. et al. Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann. Neurol. 70, 897–912 (2011).
Zhernakova, A. et al. Meta-analysis of genome-wide association studies in celiac disease and rheumatoid arthritis identifies fourteen non-HLA shared loci. PLoS Genet. 7, e1002004 (2011).
Webb, C. et al. Celiac disease can be predicted by high levels of anti-tissue transglutaminase antibodies in population-based screening. J. Pediatr. Gastroenterol. Nutr. 60, 787–791 (2015).
Altobelli, E., Paduano, R., Petrocelli, R. & Di Orio, F. Burden of celiac disease in Europe: a review of its childhood and adulthood prevalence and incidence as of September 2014. Ann. Ig. 26, 485–498 (2014).
Mustalahti, K. et al. The prevalence of celiac disease in Europe: results of a centralized, international mass screening project. Ann. Med. 42, 587–595 (2010).
Ivarsson, A. et al. Prevalence of childhood celiac disease and changes in infant feeding. Pediatrics 131, e687–e694 (2013).
Rubio-Tapia, A., Ludvigsson, J. F., Brantner, T. L., Murray, J. A. & Everhart, J. E. The prevalence of celiac disease in the United States. Am. J. Gastroenterol. 107, 1538–1544 (2012).
Nenna, R. et al. The celiac iceberg: characterization of the disease in primary schoolchildren. J. Pediatr. Gastroenterol. Nutr. 56, 416–421 (2013).
Mearin, M. L., Ivarsson, A. & Dickey, W. Coeliac disease: is it time for mass screening? Best Pract. Res. Clin. Gastroenterol. 19, 441–452 (2005).
Godfrey, J. D. et al. Morbidity and mortality among older individuals with undiagnosed celiac disease. Gastroenterology 139, 763–769 (2010).
Catassi, C. & Fasano, A. Coeliac disease. The debate on coeliac disease screening—are we there yet? Nature Rev. Gastroenterol. Hepatol 11, 457–458 (2014).
Mooney, P. D., Hadjivassiliou, M. & Sanders, D. S. Coeliac disease. BMJ 348, g1561 (2014).
Hill, I. D. Management of celiac disease in children. UpToDate[online], (2015).
Leffler, D. A. & Schuppan, D. Update on serologic testing in celiac disease. Am. J. Gastroenterol. 105, 2520–2524 (2010).
Biagi, F., Klersy, C., Balduzzi, D. & Corazza, G. R. Are we not over-estimating the prevalence of coeliac disease in the general population? Ann. Med. 42, 557–561 (2010).
Castellaneta, S. et al. High rate of spontaneous normalization of celiac serology in a cohort of 446 children with type 1 diabetes: a prospective study. Diabetes Care 38, 760–766 (2015).
Maki, M. et al. Prevalence of celiac disease among children in Finland. N. Engl. J. Med. 348, 2517–2524 (2003).
Simell, S. et al. Natural history of transglutaminase autoantibodies and mucosal changes in children carrying HLA-conferred celiac disease susceptibility. Scand. J. Gastroenterol. 40, 1182–1191 (2005).
Romanos, J. & Wijmenga, C. Predicting susceptibility to celiac disease by genetic testing profile. Ann. Gastroenterol. Hepatol. 1, 11–18 (2010).
Liu, E. et al. Risk of pediatric celiac disease according to HLA haplotype and country. N. Engl. J. Med. 371, 42–49 (2014).
Panetta, F. et al. Clinical accuracy of anti-tissue transglutaminase as screening test for celiac disease under 2 years. Acta Paediatr. 100, 728–731 (2011).
Tortora, R. et al. The presence of anti-endomysial antibodies and the level of anti-tissue transglutaminases can be used to diagnose adult coeliac disease without duodenal biopsy. Aliment. Pharmacol. Ther. 40, 1223–1229 (2014).
Vriezinga, S. L. et al. Randomized feeding intervention in infants at high risk for celiac disease. N. Engl. J. Med. 371, 1304–1315 (2014).
Lionetti, E. et al. Introduction of gluten, HLA status, and the risk of celiac disease in children. N. Engl. J. Med. 371, 1295–1303 (2014).
Abraham, G. et al. Accurate and robust genomic prediction of celiac disease using statistical learning. PLoS Genet. 10, e1004137 (2014).
Romanos, J. et al. Improving coeliac disease risk prediction by testing non-HLA variants additional to HLA variants. Gut 63, 415–422 (2014).
Christophersen, A. et al. Tetramer-visualized gluten-specific CD4+ T cells in blood as a potential diagnostic marker for coeliac disease without oral gluten challenge. United European Gastroenterol. J. 2, 268–278 (2014).
Ventura, A., Magazzu, G. & Greco, L. Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease. SIGEP Study Group for Autoimmune Disorders in Celiac Disease. Gastroenterology 117, 297–303 (1999).
Sategna Guidetti, C., Solerio, E., Scaglione, N., Aimo, G. & Mengozzi, G. Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders. Gut 49, 502–505 (2001).
Viljamaa, M. et al. Coeliac disease, autoimmune diseases and gluten exposure. Scand. J. Gastroenterol. 40, 437–443 (2005).
Cosnes, J. et al. Incidence of autoimmune diseases in celiac disease: protective effect of the gluten-free diet. Clin. Gastroenterol. Hepatol 6, 753–758 (2008).
Schmid, S., Buuck, D., Knopff, A., Bonifacio, E. & Ziegler, A. G. BABYDIET, a feasibility study to prevent the appearance of islet autoantibodies in relatives of patients with Type 1 diabetes by delaying exposure to gluten. Diabetologia 47, 1130–1131 (2004).
Hummel, S., Pfluger, M., Hummel, M., Bonifacio, E. & Ziegler, A. G. Primary dietary intervention study to reduce the risk of islet autoimmunity in children at increased risk for type 1 diabetes: the BABYDIET study. Diabetes Care 34, 1301–1305 (2011).
Daifotis, A. G., Koenig, S., Chatenoud, L. & Herold, K. C. Anti-CD3 clinical trials in type 1 diabetes mellitus. Clin. Immunol. 149, 268–278 (2013).
Mollazadegan, K. et al. Risk of renal disease in patients with both type 1 diabetes and coeliac disease. Diabetologia 57, 1339–1345 (2014).
Mollazadegan, K. et al. A population-based study of the risk of diabetic retinopathy in patients with type 1 diabetes and celiac disease. Diabetes Care 36, 316–321 (2013).
Mollazadegan, K., Sanders, D. S., Ludvigsson, J. & Ludvigsson, J. F. Long-term coeliac disease influences risk of death in patients with type 1 diabetes. J. Intern. Med. 274, 273–280 (2013).
Malalasekera, V., Cameron, F., Grixti, E. & Thomas, M. C. Potential reno-protective effects of a gluten-free diet in type 1 diabetes. Diabetologia 52, 798–800 (2009).
Amin, R. et al. A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease. Diabetes Care 25, 1117–1122 (2002).
Kaukinen, K. et al. No effect of gluten-free diet on the metabolic control of type 1 diabetes in patients with diabetes and celiac disease. Retrospective and controlled prospective survey. Diabetes Care 22, 1747–1748 (1999).
Sun, S. et al. The effect of biopsy-positive silent coeliac disease and treatment with a gluten-free diet on growth and glycaemic control in children with Type 1 diabetes. Diabet. Med. 26, 1250–1254 (2009).
Scaramuzza, A. E., Mantegazza, C., Bosetti, A. & Zuccotti, G. V. Type 1 diabetes and celiac disease: The effects of gluten free diet on metabolic control. World J. Diabetes 4, 130–134 (2013).
Sanchez-Albisua, I. et al. Coeliac disease in children with Type 1 diabetes mellitus: the effect of the gluten-free diet. Diabet. Med. 22, 1079–1082 (2005).
Hansen, D. et al. Clinical benefit of a gluten-free diet in type 1 diabetic children with screening-detected celiac disease: a population-based screening study with 2 years' follow-up. Diabetes Care 29, 2452–2456 (2006).
Taler, I. et al. Growth and metabolic control in patients with type 1 diabetes and celiac disease: a longitudinal observational case–control study. Pediatr. Diabetes 13, 597–606 (2012).
Sategna-Guidetti, C. et al. Prevalence of thyroid disorders in untreated adult celiac disease patients and effect of gluten withdrawal: an Italian multicenter study. Am. J. Gastroenterol. 96, 751–757 (2001).
Metso, S. et al. Gluten-free diet and autoimmune thyroiditis in patients with celiac disease. A prospective controlled study. Scand. J. Gastroenterol. 47, 43–48 (2012).
Ludvigsson, J. F., Elfstrom, P., Broome, U., Ekbom, A. & Montgomery, S. M. Celiac disease and risk of liver disease: a general population-based study. Clin. Gastroenterol. Hepatol. 5, 63–69 (2007).
Rubio-Tapia, A. et al. Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int. 28, 467–476 (2008).
Kaukinen, K. et al. Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure. Gastroenterology 122, 881–888 (2002).
Long, K. H. et al. The economics of coeliac disease: a population-based study. Aliment. Pharmacol. Ther. 32, 261–269 (2010).
Green, P. H. et al. Economic benefits of increased diagnosis of celiac disease in a national managed care population in the United States. J. Insur. Med. 40, 218–228 (2008).
Celiac Support Association. Celiac Disease Facts. Celiac Support Association[online], (2015).
Violato, M., Gray, A., Papanicolas, I. & Ouellet, M. Resource use and costs associated with coeliac disease before and after diagnosis in 3,646 cases: results of a UK primary care database analysis. PLoS ONE 7, e41308 (2012).
Bevan, S., Popat, S. & Houlston, R. S. Relative power of linkage and transmission disequilibrium test strategies to detect non-HLA linked coeliac disease susceptibility genes. Gut 45, 668–671 (1999).
Hunt, K. A. et al. Newly identified genetic risk variants for celiac disease related to the immune response. Nat. Genet. 40, 395–402 (2008).
Zhernakova, A., van Diemen, C. C. & Wijmenga, C. Detecting shared pathogenesis from the shared genetics of immune-related diseases. Nat. Rev. Genet. 10, 43–55 (2009).
Trynka, G. et al. Dense genotyping identifies and localizes multiple common and rare variant association signals in celiac disease. Nat. Genet. 43, 1193–1201 (2011).
Cortes, A. & Brown, M. A. Promise and pitfalls of the Immunochip. Arthritis Res. Ther. 13, 101 (2011).
Festen, E. A. et al. A meta-analysis of genome-wide association scans identifies IL18RAP, PTPN2, TAGAP, and PUS10 as shared risk loci for Crohn's disease and celiac disease. PLoS Genet. 7, e1001283 (2011).
We thank J. Senior (University of Groningen, University Medical Centre, Department of Genetics, Groningen, Netherlands) and L. M. Sollid (Centre for Immune Regulation, University of Oslo, Oslo, Norway) for carefully reading the manuscript. The work in the Wijmenga laboratory on coeliac disease is funded by the European Research Council advanced grant (FP/2007–2013/ERC grant 2012-322698). K.E.A.L. is a senior faculty member at the Centre of Immune Regulation, which is funded by the Research Council of Norway through its Centres of Excellence funding scheme, project number 179573/V40, European Research Council advanced grant (FP/2007–2013/ERC grant 2010-268541 to L. M. Sollid), South-Eastern Norway Regional Health Authority and the Norwegian ExtraFoundation for Health and Rehabilitation through EXTRA funds.
The authors declare no competing financial interests.
About this article
Cite this article
Lundin, K., Wijmenga, C. Coeliac disease and autoimmune disease—genetic overlap and screening. Nat Rev Gastroenterol Hepatol 12, 507–515 (2015). https://doi.org/10.1038/nrgastro.2015.136
This article is cited by
Single cell transcriptomic analysis of the immune cell compartment in the human small intestine and in Celiac disease
Nature Communications (2022)
Food groups associated with immune-mediated inflammatory diseases: a Mendelian randomization and disease severity study
European Journal of Clinical Nutrition (2021)
Exploring celiac disease candidate pathways by global gene expression profiling and gene network cluster analysis
Scientific Reports (2020)
The Impact of a Gluten-Free Diet on Celiac Disease: A Comprehensive Evaluation of Two Cases Using NIH Patient Reported Outcome Measures (PROMIS, NTCB, and Neuro-QoL)
Journal of Clinical Psychology in Medical Settings (2020)
BMC Medicine (2019)